BERTOLANI, A.; RAVASIO, R.; RAIMONDO, P.; JOMMI, C. The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study. Global and Regional Health Technology Assessment, [S. l.], v. 9, n. 1, p. 73–81, 2022. DOI: 10.33393/grhta.2022.2415. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2415. Acesso em: 16 may. 2024.